Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System
Dr. Cipto Mangunkusumo Hospital Treats Indonesia's First Patient on Varian's Halcyon System |
[01-July-2020] |
PALO ALTO, California and SINGAPORE, July 1, 2020 /PRNewswire/ -- Dr. Cipto Mangunkusumo Hospital, Jakarta has become the first hospital in Indonesia to treat patients using Varian's Halcyonâ„¢ system. The first patient, a 14 year old female, was treated for Hodgkin lymphoma. By 2040, more than 575,000 cancer cases are predicted to be reported in Indonesia. This signifies nearly a two-thirds increase from the 350,000 cases that were estimated in 2018.[1] Prof. Soehartati A. Gondhowiardjo, MD, PhD, Senior Radiation Oncologist, Cipto Mangunkusumo National General Hospital, said: "We are proud to be the first hospital in Indonesia to be able to offer the high quality of care, operational excellence, and fully image-guided radiation therapy to our patients. Compared to our existing Varian linear accelerator, Halcyon is much easier and intuitive to operate. We are delighted to be at the forefront of bringing this innovation to the people of Indonesia." Halcyon features a streamlined workflow that only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies. To assist in the reduction of time and construction costs from installation to first patient treatment, Halcyon offers expedited commissioning, requires less shielding than traditional systems, can fit in a majority of the existing small vaults, and can be installed in two weeks or less. The system is well suited to treat a majority of cancer patients, offering advanced treatments for lung, prostate, breast, head & neck, and many other forms of cancer. Kevin Lo, managing director, Southeast Asia, Korea, Hong Kong & Macau Region, Varian Asia Pacific, said: "We are delighted to partner with Dr. Cipto Mangunkusumo Hospital to bring the first Halcyon radiotherapy system to Indonesia. We strive to bring advanced technology to cancer patients across all communities. Cancer patients in Indonesia now have access to cutting edge technology in their fight against cancer." About Varian [1] International Agency for Research on Cancer, Cancer Tomorrow. Accessed on 16 March 2020: https://gco.iarc.fr/tomorrow/graphic-isotype?type=0&population=900&mode=population&sex=0&cancer=39&age_group=value&apc_male=0&apc_female=0 Press Contact Investor Relations Contact SOURCE Varian Medical Systems | ||
Company Codes: NYSE:VAR |
© 2020 PR Newswire. All Rights Reserved.